ES2180636T3 - Emulsiones antimicrobianas de aceite en agua. - Google Patents

Emulsiones antimicrobianas de aceite en agua.

Info

Publication number
ES2180636T3
ES2180636T3 ES95920506T ES95920506T ES2180636T3 ES 2180636 T3 ES2180636 T3 ES 2180636T3 ES 95920506 T ES95920506 T ES 95920506T ES 95920506 T ES95920506 T ES 95920506T ES 2180636 T3 ES2180636 T3 ES 2180636T3
Authority
ES
Spain
Prior art keywords
emulsion
chloride
antimicrobial
glicerol
bromide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920506T
Other languages
English (en)
Inventor
D Craig Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novavax Inc
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/246,868 external-priority patent/US5547677A/en
Priority claimed from US08/322,827 external-priority patent/US5549901A/en
Application filed by Novavax Inc filed Critical Novavax Inc
Application granted granted Critical
Publication of ES2180636T3 publication Critical patent/ES2180636T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE MUESTRA UNA EMULSION OLEOSA ANTIMICROBIANA QUE INCLUYE UN AGENTE SELECCIONADO A PARTIR DEL GRUPO INTEGRADO POR MONOOLEATO DE GLICEROL, TRIOLEATO DE GLICEROL, MONOLAURATO DE GLICEROL, Y DILAURATO DE GLICEROL COMO EMULSIONANTE PRIMARIO Y UN COMPUESTO QUE CONTIENE HALOGENO CATIONICO QUE TIENE UNA CADENA C{SUB,12}C{SUB,16} COMO AGENTE PRODUCTOR DE UNA CARGA POSITIVA. LA EMULSION PUEDE INCLUIR ADEMAS UN ESTEROL, PREFERIBLEMENTE FITOSTEROL. LOS COMPUESTOS CATIONICOS QUE CONTIENEN HALOGENO PREFERIDOS PARA USAR EN LA INVENCION INCLUYEN CLORURO DE CETILPIRIDINA, BROMURO DE CETILPIRIDINA, BROMURO DE CETILTRIMETILAMONIO, BROMURO DE CETILDIMETIETILAMONIO, Y CLORURO DE BENZOLCONIO. LA EMULSION ANTIMICROBIANA PUEDE USARSE EN LA FORMA DE UN PREPARADO FARMACEUTICO PARA INHIBIR EL CRECIMIENTO DE UNA AMPLIA VARIEDAD DE PATOGENOS INFECCIOSOS, INCLUYENDO BACTERIAS, HONGOS, Y VIRUS.
ES95920506T 1994-05-20 1995-05-18 Emulsiones antimicrobianas de aceite en agua. Expired - Lifetime ES2180636T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/246,868 US5547677A (en) 1994-05-20 1994-05-20 Antimicrobial oil-in-water emulsions
US08/322,827 US5549901A (en) 1994-05-20 1994-10-13 Antimicrobial oil-in-water emulsions
US32973094A 1994-10-26 1994-10-26

Publications (1)

Publication Number Publication Date
ES2180636T3 true ES2180636T3 (es) 2003-02-16

Family

ID=27399981

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920506T Expired - Lifetime ES2180636T3 (es) 1994-05-20 1995-05-18 Emulsiones antimicrobianas de aceite en agua.

Country Status (10)

Country Link
US (1) US5618840A (es)
EP (2) EP0760650B1 (es)
JP (2) JPH10500686A (es)
CN (2) CN1158069C (es)
AU (2) AU2593695A (es)
BR (2) BR9507742A (es)
CA (2) CA2190604A1 (es)
DE (2) DE69524953T2 (es)
ES (1) ES2180636T3 (es)
WO (2) WO1995031956A1 (es)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387373B1 (en) * 1993-01-15 2002-05-14 Novavax, Inc. Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
CA2238484A1 (en) * 1995-11-28 1997-06-05 Michael D. Wider Antimicrobial composition and methods of use therefor
WO1997021728A1 (en) 1995-12-12 1997-06-19 Karolinska Innovations Ab PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
ZA9610949B (en) * 1996-01-05 1997-08-14 Applied Microbiology Inc Monoglyceride compositions and their use against Helicobacter.
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5958974A (en) * 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
US5908862A (en) * 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
ATE224355T1 (de) * 1996-07-31 2002-10-15 Abbott Lab Mit wasser mischbare monoglyceridester mit antimikrobieller aktivität
DE19643587A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sterole und Sterolderivate
DE19643586A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Gegen Mikroorganismen, Viren, Parasiten und Protozoen wirksame Sterole und Sterolderivate
US6426078B1 (en) * 1997-03-17 2002-07-30 Roche Vitamins Inc. Oil in water microemulsion
US5753711A (en) * 1997-03-18 1998-05-19 Collagenex Pharmaceuticals, Inc. Method for treatment of H. pylori
FR2771637B1 (fr) * 1997-12-01 2003-10-24 Hutchinson Utilisation d'un halogenure de dialkyldialkylammonium par voie parenterale dans les infections bacteriennes et virales
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
DE19841795A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Sterole und Sterolderivate) und Mikrobiziden
DE19841796A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Kohlenhydrate) und Mikrobiziden
DE19841794A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Ceramide und Sphingosine und Derivate) und Mikrobiziden
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US8236335B2 (en) 1999-04-28 2012-08-07 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6635676B2 (en) 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6559189B2 (en) 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US7767216B2 (en) 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
FR2804868B1 (fr) * 2000-02-15 2003-03-07 Oreal Utilisation de composes permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
FR2804865B1 (fr) * 2000-02-15 2003-11-28 Oreal Utilisation des corps gras particuliers permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
WO2004030608A2 (en) * 2001-06-05 2004-04-15 The Regents Of The University Of Michigan Nanoemulsion vaccines
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
WO2003020024A2 (en) * 2001-08-28 2003-03-13 Eden Research Plc Treatment and prevention of infections in plants
US20030180349A1 (en) * 2001-12-07 2003-09-25 Franklin Lanny U. Respiratory infection prevention and treatment with terpene-containing compositions
EP1487504A4 (en) * 2002-02-19 2010-09-01 Eden Research Plc IMPROVING THE QUALITY OF THE INTERIOR AIR AND ANTISEPTIC COMPOSITION INTENDED FOR THIS PURPOSE
US20030228402A1 (en) * 2002-02-19 2003-12-11 Franklin Lanny U. Compositions and methods for preservation of food
US20040087564A1 (en) * 2002-10-31 2004-05-06 Wright D. Craig Delivery composition and method
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
WO2005002535A1 (en) * 2003-07-03 2005-01-13 Betafarma S.P.A. Antibacterial mouthwash
EP1648412B1 (en) * 2003-07-07 2007-11-14 Nares AB Microemulsions and its use for preventing airway diseases
US8211448B2 (en) 2003-07-07 2012-07-03 Nares Ab Microemulsions and its use for preventing airway diseases
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
FR2861295B1 (fr) * 2003-10-23 2005-12-23 Oreal Emulsion h/e cosmetique ou dermatologique de ph stable
EP1686993B1 (en) * 2003-11-07 2011-01-12 Viratox, L.L.C. Virucidal activities of a composition comprising cetylpyridinium chloride and citric acid
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
WO2005047475A2 (en) * 2003-11-11 2005-05-26 Regents Of The University Of Minnesota Regulation of cell membrane-mediated effects
SI1711058T1 (sl) 2004-01-23 2022-02-28 Eden Research Plc, Postopki za uničevanje nematod, ki obsega uporabo terpenske komponente
CN1997446B (zh) 2004-05-20 2012-01-04 伊顿研究有限公司 含有包封萜成分的中空葡聚糖颗粒或细胞壁颗粒的组合物、其制备和使用方法
US20050260138A1 (en) * 2004-05-21 2005-11-24 Virgil Flanigan Producton and use of a gaseous vapor disinfectant
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
EP1812550A2 (en) * 2004-10-20 2007-08-01 Iogenetics, Llc Biocides
US10918618B2 (en) 2005-03-10 2021-02-16 3M Innovative Properties Company Methods of reducing microbial contamination
TW200724134A (en) 2005-03-10 2007-07-01 3M Innovative Properties Co Antimicrobial compositions and methods
CA2604392A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
WO2008051186A2 (en) * 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
KR101478012B1 (ko) 2005-11-30 2015-01-02 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
WO2007063267A1 (en) 2005-11-30 2007-06-07 Eden Research Plc Terpene-containing compositions and methods of making and using them
US20090321534A1 (en) * 2005-12-02 2009-12-31 Nfd, Llc Aerosol or gaseous decontaminant generator and application thereof
US20080038295A1 (en) * 2006-04-13 2008-02-14 Regents Of The University Of Michigan Compositions and methods for orthopox virus vaccination
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) * 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
WO2008103416A1 (en) * 2007-02-21 2008-08-28 Capps Charles L Synergistic enhancement of calcium propionate
US8747872B2 (en) * 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
WO2009088894A2 (en) 2007-12-31 2009-07-16 3M Innovative Properties Company Antimicrobial compositions
EP2237684A2 (en) * 2008-01-08 2010-10-13 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
US20090291095A1 (en) * 2008-05-23 2009-11-26 The Regents Of The University Of Michigan Nanoemulsion adjuvants
US9415006B2 (en) * 2008-05-23 2016-08-16 The Regents Of The University Of Michigan Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
AU2009296458A1 (en) 2008-09-26 2010-04-01 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
JP2012509932A (ja) * 2008-11-26 2012-04-26 ビロブロック エスアー 非リン脂質脂質小胞を使用してグラム陽性菌を抑制する方法
WO2010132833A1 (en) 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
US20100316673A1 (en) * 2009-06-16 2010-12-16 The Regents Of The University Of Michigan Nanoemulsion vaccines
FR2950884B1 (fr) * 2009-10-01 2011-11-11 Oreal Utilisation de derives de vanilline comme conservateur, procede de conservation, composes et composition
DK2563375T3 (da) * 2010-04-28 2014-08-18 Alcon Res Ltd Farmaceutiske sammensætninger med phosphonium-antimikrobielle midler
US8747534B2 (en) * 2010-12-29 2014-06-10 United States Gypsum Company Antimicrobial size emulsion and gypsum panel made therewith
AU2013249086A1 (en) * 2012-04-20 2014-10-30 Hennepin Life Sciences Compositions for topical treatment of microbial infections
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
CA2963569A1 (en) * 2013-11-04 2015-05-07 Atp Institute Pty Ltd Vasodilator formulation and method of use
EP3204039B1 (en) 2014-10-10 2022-06-08 The Regents Of The University Of Michigan Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
FR3030279B1 (fr) * 2014-12-17 2019-08-02 Tereos Starch & Sweeteners Belgium Composition antibacterienne contenant un melange isomerique de monoethers ou de monoacetals d'alkyle de monosaccharides
WO2016154010A1 (en) 2015-03-20 2016-09-29 Makidon Paul Immunogenic compositions for use in vaccination against bordetella
WO2017063150A1 (zh) * 2015-10-14 2017-04-20 高雄医学大学 酪梨萃取物、avocadenol B及(2R,4R)-1,2,4-三羟基十七碳-16-炔的用途，以及包含酪梨萃取物的保健食品
US11369578B2 (en) 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
FR3093650B1 (fr) 2019-03-11 2022-12-30 Id4Feed Nouveau solvant d’extraction, de solubilisation et/ou de formulation de composés volatiles et non-volatiles d’intérêt en alimentation et santé animale, procédé de préparation et utilisations associées
EP4121026A4 (en) * 2020-03-17 2024-04-10 Bluewillow Biologics Inc PERSISTENT TOPICAL ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
EP4135660A1 (en) * 2020-04-16 2023-02-22 Atossa Therapeutics, Inc. Compositions and methods to reduce the infectivity of a virus
FR3110342A1 (fr) 2020-05-21 2021-11-26 Id4Feed Procédé de préparation d’un totum ou d’un filtrat permettant la stabilisation de matière végétale fraîche

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321257A (en) * 1974-07-08 1982-03-23 Johnson & Johnson Potentiated medicaments
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
US4197318A (en) * 1974-07-08 1980-04-08 Johnson & Johnson Potentiated antimicrobial medicaments
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
US4474748A (en) * 1979-09-26 1984-10-02 Johnson & Johnson Medicaments potentiated with phenyl alkanols
JPS6027646B2 (ja) * 1979-10-31 1985-06-29 花王株式会社 化粧料
US4323551A (en) * 1981-02-19 1982-04-06 The Procter & Gamble Company Mouthwash compositions
US4902720A (en) * 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides
GB8809177D0 (en) * 1988-04-19 1988-05-25 Merrell Doe Pharmaceuticals In Method of preventing aids transmission-resulting from blood transfusions
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
EP0510165B1 (fr) * 1990-11-14 1995-01-25 L'oreal Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
US5176901A (en) * 1991-04-10 1993-01-05 Smithkline Beecham Corporation Dental composition
US5300305A (en) * 1991-09-12 1994-04-05 The Procter & Gamble Company Breath protection microcapsules
CA2082561A1 (en) * 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
DE69430799T2 (de) * 1993-03-22 2003-02-13 Cognis Australien Pty Ltd Wasserdispersible therapeutische carotenoid verbindungen
US5403587A (en) * 1993-04-22 1995-04-04 Eastman Kodak Company Disinfectant and sanitizing compositions based on essential oils
US5534544A (en) * 1994-08-19 1996-07-09 New England Medical Center Hospitals, Inc. Surfactants and emulsifying agents to inhibit Helicobacter

Also Published As

Publication number Publication date
AU687562B2 (en) 1998-02-26
CA2190606A1 (en) 1995-11-30
EP0760650A4 (en) 1998-11-25
CN1159158A (zh) 1997-09-10
JPH10500686A (ja) 1998-01-20
WO1995031966A1 (en) 1995-11-30
EP0765151A1 (en) 1997-04-02
EP0765151A4 (en) 1998-11-25
EP0765151B1 (en) 2002-01-09
BR9507742A (pt) 1997-10-07
US5618840A (en) 1997-04-08
CN1158069C (zh) 2004-07-21
EP0760650B1 (en) 2002-07-31
AU2593795A (en) 1995-12-18
DE69527624T2 (de) 2003-04-03
EP0760650A1 (en) 1997-03-12
CA2190604A1 (en) 1995-11-30
DE69524953T2 (de) 2002-08-29
AU2593695A (en) 1995-12-18
WO1995031956A1 (en) 1995-11-30
CN1156404A (zh) 1997-08-06
DE69527624D1 (de) 2002-09-05
DE69524953D1 (de) 2002-02-14
BR9507669A (pt) 1997-10-07
JPH10500687A (ja) 1998-01-20

Similar Documents

Publication Publication Date Title
ES2180636T3 (es) Emulsiones antimicrobianas de aceite en agua.
ES2549766T3 (es) Compuestos antimicrobianos y métodos para su utilización
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
BRPI0618374A2 (pt) uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo
AR024874A1 (es) Composiciones bactericidas
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
ES2169759T3 (es) Procedimiento de preparacion de emulsiones y microcapsulas que contienen aceite natural y uso del mismo.
ES2107196T3 (es) Metodo para desinfectar agua, tal como agua de desague en horticultura y aparato que se usa para ello.
BR9814636A (pt) "isotiazolcarboxamidas"
CN108617650A (zh) 一种复合杀菌剂及其制备方法
ES2159043T3 (es) Derivado carboestirilico para el tratamiento de enfermedades oculares.
ATE473749T1 (de) Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
CN107094807A (zh) 一种中草药绿色无害消毒剂
PT1079790E (pt) Utilizacao de composicoes microbicidas e espermicidas para inactivacao de virus sem envelope
ES2194535T3 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contien y su uso como agente parala lucha contra organismos dañinos.
AR032066A1 (es) Agente para tratamiento terapeutico y profilactico del dolor neuropatico
CN103011379A (zh) 水产养殖解毒净水剂
BRPI0416768A (pt) fagos isolados e seu uso como desinfetantes em alimentos ou para sanitização de ambientes de fábricas
AR008538A1 (es) Emulsion del tipo aceite en agua
ES2095657T3 (es) Derivado de triazol, procedimiento de obtencion del mismo, un agente de control de plagas y metodo de control de plagas.
BR0114318A (pt) Composições de limpeza e desinfetantes para superfìcies duras
BR0012796A (pt) Composição de cisplatina farmacêutica estéril como uma emulsão de óleo-em-água dotada de baixa toxicidade para administração parenteral e processo para a preparação da mesma
KR20230054661A (ko) 피부에 적용하기 위한 소독성, 피부 허용성 관리제
KR20230074114A (ko) 피부에 적용하기 위한 소독성, 피부 허용성, 과지방 관리제
WO1993000813A1 (es) Composiciones germicidas que contienen compuestos yodados